[
  {
    "ts": "2025-10-03T11:57:28+00:00",
    "headline": "Is Now the Right Moment to Reassess Zoetis After Recent FDA Approval News?",
    "summary": "Standing at a crossroads with Zoetis? If you have been tracking the animal health giant, you have definitely noticed the rollercoaster ride its stock price has taken lately. After a solid 3.8% bounce in the last week, the stock is still down 4.2% over the past month and down almost 10% year to date. Over the longer haul, returns look even rougher with a 22.4% drop in the past year and a 6.3% decline in five years. Naturally, these numbers might make you wonder: does this slump open the door...",
    "url": "https://finance.yahoo.com/news/now-moment-reassess-zoetis-recent-115728284.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bfc9d29e-8b8c-377f-b5fe-e43f1b1059ab",
      "content": {
        "id": "bfc9d29e-8b8c-377f-b5fe-e43f1b1059ab",
        "contentType": "STORY",
        "title": "Is Now the Right Moment to Reassess Zoetis After Recent FDA Approval News?",
        "description": "",
        "summary": "Standing at a crossroads with Zoetis? If you have been tracking the animal health giant, you have definitely noticed the rollercoaster ride its stock price has taken lately. After a solid 3.8% bounce in the last week, the stock is still down 4.2% over the past month and down almost 10% year to date. Over the longer haul, returns look even rougher with a 22.4% drop in the past year and a 6.3% decline in five years. Naturally, these numbers might make you wonder: does this slump open the door...",
        "pubDate": "2025-10-03T11:57:28Z",
        "displayTime": "2025-10-03T11:57:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f0C7t6iQjaUXO6Sb_gR7gg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xjacLb9JseQC0Y25VVBzKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/now-moment-reassess-zoetis-recent-115728284.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/now-moment-reassess-zoetis-recent-115728284.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]